Literature DB >> 28105342

Five percent dextrose maximizes dose delivery of Yttrium-90 resin microspheres and reduces rates of premature stasis compared to sterile water.

Mary Ellen Koran1, Samantha Stewart1, Jennifer C Baker1, Andrew J Lipnik1, Fil Banovac1, Reed A Omary1, Daniel B Brown1.   

Abstract

Resin Yttrium-90 (Y90) microspheres have historically been infused using sterile water (H2O). In 2013, recommendations expanded to allow delivery with 5% dextrose in water (D5W). In this retrospective study, we hypothesized that D5W would improve Y90 delivery with a lower incidence of stasis. We reviewed 190 resin Y90 infusions using H2O (n=137) or D5W (n=53). Y90 dosimetry was calculated using the body surface area method. Infusion was halted if intra-arterial stasis was fluoroscopically identified prior to clearing the vial. Differences between H2O and D5W groups were calculated for activity prescription, percentage of cases reaching stasis, and percentage delivery of prescribed activity using z- and t-test comparisons, with α=0.05. Thirty-one of 137 H2O infusions developed stasis compared to 2 of 53 with D5W (z=3.07, p=1.05E-03). D5W also had a significantly higher prescribed activity than H2O [28.2 millicuries (mCi) vs. 20.4 mCi, respectively; t=5.0, p=1.1E-6]. D5W had a higher delivery percentage of the prescribed dose compared to H2O (101.5 vs. 92.7%, respectively; t=3.8, p=1.92E-4). In conclusion, resin microsphere infusion utilizing D5W has a significantly lower rate of stasis than H2O and results in more complete dose delivery. D5W is preferable to H2O for resin microsphere infusion.

Entities:  

Keywords:  liver; locoregional therapy; metastatic disease; palliative therapy; radioembolization; yttrium-90

Year:  2016        PMID: 28105342      PMCID: PMC5228356          DOI: 10.3892/br.2016.799

Source DB:  PubMed          Journal:  Biomed Rep        ISSN: 2049-9434


  18 in total

1.  Erythrocytes possess an intrinsic barrier to nitric oxide consumption.

Authors:  M W Vaughn; K T Huang; L Kuo; J C Liao
Journal:  J Biol Chem       Date:  2000-01-28       Impact factor: 5.157

2.  Transcatheter arterial chemoembolization of liver tumors: effects of embolization protocol on injectable volume of chemotherapy and subsequent arterial patency.

Authors:  Jean-Francois H Geschwind; Douglas E Ramsey; Berry Cleffken; B C H van der Wal; Hicham Kobeiter; Krishna Juluru; George G Hartnell; Michael A Choti
Journal:  Cardiovasc Intervent Radiol       Date:  2003-03-06       Impact factor: 2.740

3.  Yttrium-90 radioembolization stops progression of targeted breast cancer liver metastases after failed chemotherapy.

Authors:  Andrew C Gordon; William J Gradishar; Virginia G Kaklamani; Avesh J Thuluvath; Robert K Ryu; Kent T Sato; Vanessa L Gates; Riad Salem; Robert J Lewandowski
Journal:  J Vasc Interv Radiol       Date:  2014-08-22       Impact factor: 3.464

Review 4.  The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: a novel mechanism of human disease.

Authors:  Russell P Rother; Leonard Bell; Peter Hillmen; Mark T Gladwin
Journal:  JAMA       Date:  2005-04-06       Impact factor: 56.272

5.  Intravenous infusion of sterile water for the treatment of hypernatraemia.

Authors:  H Ramaswamykanive; J Greaves
Journal:  Anaesth Intensive Care       Date:  2014-03       Impact factor: 1.669

6.  Yttrium 90 resin microspheres for the treatment of unresectable colorectal hepatic metastases after failure of multiple chemotherapy regimens: preliminary results.

Authors:  Ravi Murthy; Henry Xiong; Rodolfo Nunez; Alan C Cohen; Bruce Barron; Janio Szklaruk; David C Madoff; Sanjay Gupta; Michael J Wallace; Kamran Ahrar; Marshall E Hicks
Journal:  J Vasc Interv Radiol       Date:  2005-07       Impact factor: 3.464

7.  The kidneys in paroxysmal nocturnal hemoglobinuria.

Authors:  D A Clark; S A Butler; V Braren; R C Hartmann; D E Jenkins
Journal:  Blood       Date:  1981-01       Impact factor: 22.113

8.  Twelve-year experience of radioembolization for colorectal hepatic metastases in 214 patients: survival by era and chemotherapy.

Authors:  Robert J Lewandowski; Khairuddin Memon; Mary F Mulcahy; Ryan Hickey; Karen Marshall; Melissa Williams; Krystina Salzig; Vanessa L Gates; Bassel Atassi; Michael Vouche; Rohi Atassi; Kush Desai; Elias Hohlastos; Kent Sato; Ali Habib; Sheetal Kircher; Steven B Newman; Halla Nimeiri; Al B Benson; Riad Salem
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-06-07       Impact factor: 9.236

9.  Involvement of nitric oxide in human transient lower esophageal sphincter relaxations and esophageal primary peristalsis.

Authors:  D P Hirsch; R H Holloway; G N Tytgat; G E Boeckxstaens
Journal:  Gastroenterology       Date:  1998-12       Impact factor: 22.682

10.  Early arterial stasis during resin-based yttrium-90 radioembolization: incidence and preliminary outcomes.

Authors:  Peachy Mae Piana; Voichita Bar; Laura Doyle; Rani Anne; Takami Sato; David J Eschelman; Jeffrey W McCann; Carin F Gonsalves; Daniel B Brown
Journal:  HPB (Oxford)       Date:  2013-06-19       Impact factor: 3.647

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.